Skip to main content
. 2020 Sep 30;23(3):173–178. doi: 10.3831/KPI.2020.23.3.173

Table 2.

Comparing topical Betamethasone and Olivederma on SCORAD severity index of patients with atopic dermatitis randomly allocated in interventions

Indices Phase Betamethasone Olivederma p-value*
SCORAD- A Baseline 44.4 ± 8.7 75.1 ± 7.2 < 0.001
6th week 35.5 ± 9.9 23.3 ± 13.6
p-value# 0.006 < 0.001
SCORAD- B Baseline 9.6 ± 1.5 9.4 ± 1.7 < 0.001
6th week 8.1 ± 2.3 3.2 ± 1.8
p-value# 0.004 < 0.001
SCORAD- C Baseline 15.8 ± 2.7 19.5 ± 0.9 < 0.001
6th week 15.2 ± 3.4 8.2 ± 5.7
p-value# 0.545 < 0.001
SCORAD total Baseline 58.4 ± 7.3 67.3 ± 6.3 < 0.001
6th week 50.5 ± 10.7 23.9 ± 13.3
p-value# 0.003 < 0.001

#Within-group (time effect) significance.

*Between-group (intervention * time effect) significance.